	Validation of the 7-Item Quality of Life Disease-Specific Impact Scale in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Cross-Sectional Study. Int J Urol Shimizu S, Osawa T, Sato M, Yamada S, Harabayashi T, Miki J, Kobayashi T, Hashine K, Kawashima A, Matsumoto T, Mochizuki T, Taoka R, Urabe F, Tatarano S, Sawada A, Kojima T, Takahashi A, Yokomizo A, Suekane S, Hashimoto K, Hashimoto Y, Yatsuda J, Morita K, Kobayashi K, Satake Y, Sazawa A, Matsui Y, Ito YM, Nishiyama H, Kitamura H, Shinohara N, Fukuhara S, Japanese Urological Oncology Group. PMID: 41603128 [PubMed - indexed for MEDLINE]
	Research advances on the risk of prostate cancer from phthalates exposure: from epidemiological evidence to multidimensional prevention and control. Front Cell Dev Biol Wang B, Cao H, Li S, Tang Z, Huang G, Li Z, Ma Y, Wei W, Chen M. PMID: 41602838 [PubMed]
	The fall of the genome protectors triad: PBRM1, SETD2, and BAP1's impact on metabolism and immunity in clear cell renal cell carcinoma. Front Cell Dev Biol Johnson M, Turcotte S. PMID: 41602827 [PubMed]
	A Deep Learning-Generated Mixed Tumor-Stroma Ratio for Prognostic Stratification and Multi-omics Profiling in Bladder Cancer. Research (Wash D C) He Y, Xie J, Zhong S, Zhan C, Dai F, Lai H, Wang M, He Y, Patel H, Chen ZS, Zhong B, Qiu X, Guo Y, Zheng Z. PMID: 41602481 [PubMed]
	A Case of Metachronous Prostate Adenocarcinoma and Chromophobe Renal Cell Carcinoma in a Nigerian Male Patient: Diagnostic and Therapeutic Challenges. Cureus Badero OJ, Ogunlana C, Alabi A, Isibor V. PMID: 41602248 [PubMed]
	Association of genetically instrumented HMGCR inhibition with the therapeutic role of prostate cancer: a Mendelian randomization study and supporting in vitro experiments. Front Pharmacol Hao X, Mu J. PMID: 41601954 [PubMed]
	Histone-modifying enzymes as drivers and therapeutic targets in androgen-resistant prostate cancer. Front Endocrinol (Lausanne) Purohit TA, Bahr K, Yang B, Schultz Z, Lewis PW, Denu JM, Jarrard DF. PMID: 41601922 [PubMed - indexed for MEDLINE]
	Hexaminolevulinate blue light cystoscopy improves bladder cancer detection in comparison to white light cystoscopy: a prospective, comparative, within-patient controlled multicenter phase III bridging study in China. Front Urol Hu H, Huang J, Ma L, Zhang S, Guo J, Liu X, Guo Y, Wen J, Zhang H, Jiang S, He W, Liu C, Yuan X, Haefner M, Weber BC, Young-Halvorsen K, Li H. PMID: 41601703 [PubMed]
	Current update on toll-like receptors and prostate cancer: a decade of progress and emerging insights. Front Immunol Janjirala J, Blanton M, Ramos KS, Zhang D. PMID: 41601666 [PubMed - indexed for MEDLINE]
	The infection-microbiome-immunity axis in bladder cancer: mechanistic insights and therapeutic perspectives. Front Immunol Pan S, Cui W, Lin J, Wang Z, Li Z, Liu B. PMID: 41601648 [PubMed - indexed for MEDLINE]
	Diagnostic Efficiency of Age-Adjusted PSAD for Prostate Cancer and Clinically Significant Prostate Cancer: Construction and Nomogram Validation. J Clin Lab Anal Liu Z, Shan J, Zhang Q, Gao Y, Lv Z, Ma L, Shi H. PMID: 41601413 [PubMed - as supplied by publisher]
	Focal therapy using a novel cooled laser device for prostate cancer: early trial results. BJU Int Kam J, Hanna B, Jackson S, McCombie S, McClintock G, Roberts MJ, Teoh J, Arianayagam M, Canagasingham B, Goolam AS, Jeffery N, Winter M, Khadra M, Ko R, Mehan N, Thangasamy I, Varol C. PMID: 41601270 [PubMed - as supplied by publisher]
	The GreenBladder Study: Early Detection of Bladder Cancer in Greenland Using a Urinary Biomarker. J Clin Med Fryd ND, Albertsen N, Bernth-Andersen S, Ernst A, Jensen JB. PMID: 41598698 [PubMed]
	Emerging Therapeutic Strategies in Prostate Cancer: Targeted Approaches Using PARP Inhibition, PSMA-Directed Therapy, and Androgen Receptor Blockade with Olaparib, Lutetium ((177)Lu)Vipivotide Tetraxetan, and Abiraterone. J Clin Med Kawczak P, B. PMID: 41598623 [PubMed]
	Combining Statins with Radiotherapy for Prostate Cancer: From Photon Experience to Proton Potential. J Clin Med Saki M, Artz ME, Park J, Johnson PB, Bryant C, Balaji KC, Grewal H. PMID: 41598506 [PubMed]
	In Vivo Prostate Cancer Modelling: From the Pre-Clinical to the Clinical Setting. Life (Basel) Nascimento-Gonçalves E, Azevedo T, Medeiros C, Faustino-Rocha AI. PMID: 41598266 [PubMed]
	Minimally Invasive Ablation Strategies for Renal Cell Carcinoma Patients Ineligible for Surgery. Life (Basel) Schubert O, Sighinolfi MC, Gavi F, Panio E, Assumma S, Silvestri A, Pallotta G, Cavarra V, Russo P, Foschi N, Scarciglia E, Posa A, Maresca A, Gulino G, Cina A, Ciccarese C, Iacovelli R, Iezzi R, Rocco B. PMID: 41598228 [PubMed]
	Diet-Microbiome Relationships in Prostate-Cancer Survivors with Prior Androgen Deprivation-Therapy Exposure and Previous Exercise Intervention Enrollment. Microorganisms Raber J, O'Niel A, Kasschau KD, Pederson A, Robinson N, Guidarelli C, Chalmers C, Winters-Stone K, Sharpton TJ. PMID: 41597766 [PubMed]
	Specialized Nursing-Led Interventions for Bladder Cancer Management: A Scoping Review of Evidence and Clinical Outcomes. Medicina (Kaunas) Alqaisi O, Tai P, Storme G. PMID: 41597472 [PubMed - indexed for MEDLINE]
	From Testis to Retroperitoneum: The Role of Radiomics and Artificial Intelligence for Primary Tumors and Nodal Disease in Testicular Cancer: A Systematic Review. Medicina (Kaunas) Telecan T, Munteanu VC, Gaia-Oltean AI, Crivii CB, Capra. PMID: 41597411 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 175525

Page 1 of 8777



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy